Skip to main content
NHINational Health Investors, Inc.Sell5.0·$70.32+0.16%
SellHigh Confidence
Investment thesis

National Health Investors is a healthcare REIT with strong 37% margins, excellent free cash flow conversion, and analyst upside potential, but two consecutive earnings misses, negative price momentum, and a dividend coverage concern limit near-term entry attractiveness.

Thesis pillars

  • Reit Quality Cash ConversionStable
  • Consecutive Earnings MissesDeteriorating
  • Price Momentum Below TrendImproving
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

National Health Investors, Inc. (NHI) Stock Analysis

Falling Knife setup

SellShortHigh Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Analyst target reached at $70.32 — A.R:R 0.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2.

National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176 properties ($2.7 billion gross carrying value) primarily leased under triple-net leases to 31 tenants in 32 states, plus 26 SHOP senior housing communities (3,009... Read more

$70.32+1.3% A.UpsideScore 5.0/10#14 of 16 REIT - Healthcare Facilities
QualityF-score6 / 9FCF yield4.98%
IncomeYield5.35%(5y avg 5.77%)Payout106.36%
Stop $67.88Target $71.23(analyst − 13%)A.R:R 0.3:1
Analyst target$81.88+16.4%8 analysts
$71.23our TP
$70.32price
$81.88mean
$90

Sell if holding. Analyst target reached at $70.32 — A.R:R 0.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Score 5.0/10, high confidence.

Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 53d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.

10-K grounded · weekly refresh

About National Health Investors, Inc.

About National Health Investors, Inc.

National Health Investors generated $375.6 million in total revenues during 2025—a 12.1% increase over the prior year—from 176 triple-net-leased properties ($2.7 billion gross value) across 32 states leased to 31 tenants, plus 26 SHOP senior housing communities with 3,009 units operated by third-party managers. The portfolio comprised 110 senior housing properties, 65 skilled nursing facilities, and one hospital as of December 31, 2025. Rental income ($271.6 million, 72.3% of revenues), SHOP resident fees ($80.1 million, 21.3%), and interest and other income ($24.0 million, 6.4%) made up the revenue mix.

The company earns rental income through triple-net leases with initial terms of 10 to 15 years and one or more five-year renewal options; most leases include annual rent escalators recognized on a straight-line basis. Under the NNN structure, tenants pay taxes, utilities, insurance, and capital expenditures. The SHOP segment uses the RIDEA structure—NHI owns properties through consolidated partnerships (16 of 26 communities held in consolidated joint ventures) while third-party managers like Life Care Services operate them for a management fee. A $218.7 million note receivable portfolio, consisting of 11 mortgage loans at 7.3%–12.0%, nine mezzanine loans at 6.0%–10.0%, and four construction loans at 8.5%–9.0%, provides additional interest income and future acquisition optionality. NHI competes for healthcare real estate acquisitions with other REITs, private equity funds, banks, and insurance companies.

Show full overview

Tenant credit concentration is the dominant balance-sheet risk for NHI's Real Estate Investments segment. The 10-K discloses that a small number of tenants account for a significant percentage of rental income, and a board-level conflict of interest is flagged through a director who also chairs National HealthCare Corporation's (NHC) board. In April 2026, NHI entered a Purchase and Sale Agreement for NHC to acquire 32 skilled nursing facilities and three independent living facilities for $560 million—removing the NHC Master Lease from the portfolio and converting the company's largest tenant relationship into a one-time disposition that materially reshapes the Real Estate Investments segment.

See also: Real Estate · REIT - Healthcare Facilities

From National Health Investors, Inc.'s most recent 10-K filing, extracted June 11, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-09-14
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 202653d to earnings· next earnings call

Thesis

Rewards
Positive insider activity
Risks
Analyst target reached - limited upside remaining
Sector modifier (Real Estate): -1.2
Consecutive earnings misses (3)

Key Metrics

P/E (TTM)20.3
P/E (Fwd)21.7
Mkt Cap$3.5B
EV/EBITDA16.8
Profit Mgn38.3%
ROE10.7%
Rev Growth-2.6%
Beta0.55
Dividend5.35%
Rating analysts12

Quality Signals

Piotroski F6/9

Options Flow

P/C0.44bullish
IV62%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMTenantsmall number of tenants
    10-K Item 1A: 'A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio'

Material Events(8-K, last 90d)

  • 2026-04-21Item 1.01MEDIUM
    NHI entered Purchase and Sale Agreement to sell 32 SNFs and 3 ILFs in AL, FL, KY, MO, SC, TN, and VA to NHC for $560M. Properties currently leased under the Master Lease dated October 17, 1991.
    SEC filing →
  • 2026-04-21Item 1.02MEDIUM
    Master Agreement to Lease with NHC/OP, L.P. to be terminated upon closing of the $560M property sale. Resolves the September 2025 default dispute with NHC.
    SEC filing →
  • 2026-04-23Item 5.02MEDIUM
    CFO John L. Spaid notified intent to retire effective July 1, 2026; no disagreement with company cited. Successor Todd Siefert appointed EVP Corporate Finance effective June 1, 2026; will become CFO upon Spaid's retirement.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Revenue shrinking — -2.6% YoY. Growth thesis broken unless recovery story develops.static

Earnings Growth
0.0
Revenue Growth
1.9
Declining revenue: -3%

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Dividend Safety
2.2
Erm
5.0
Earnings Timing
5.0
Earnings concerns: 1B/3MYield trap warning: high yield but unsafe
GatesMomentum 4.1<4.5A.R:R 0.3 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 53d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Aggressive
RSI
31 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $69.73Resistance $74.73

Price Targets

$68
$71
A.Upside+1.3%
A.R:R0.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (1.3% upside)
! momentum at 4.1 (below the engine's 4.5 threshold)
! asymmetry at 0.3 (below the engine's 1.5 threshold)@spot

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-11-05 (53d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NHI stock a buy right now?

Sell if holding. Analyst target reached at $70.32 — A.R:R 0.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Prior stop was $67.88. Score 5.0/10, high confidence.

What is the NHI stock price target?

Take-profit target: $71.23 (+1.3% upside). Prior stop was $67.88. Stop-loss: $67.88.

What are the risks of investing in NHI?

Analyst target reached - limited upside remaining; Sector modifier (Real Estate): -1.2; Consecutive earnings misses (3).

Is NHI overvalued or undervalued?

National Health Investors, Inc. trades at a P/E of 20.3 (forward 21.7). TrendMatrix value score: 4.9/10. Verdict: Sell.

What do analysts say about NHI?

12 analysts cover NHI with a consensus score of 3.8/5. Average price target: $82.

What does National Health Investors, Inc. do?National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176...

National Health Investors is a self-managed healthcare REIT with $375.6 million in 2025 total revenues, owning 176 properties ($2.7 billion gross carrying value) primarily leased under triple-net leases to 31 tenants in 32 states, plus 26 SHOP senior housing communities (3,009 units) operated by third-party managers.

Related stocks: OHI (Omega Healthcare Investors, Inc) · AHR (American Healthcare REIT, Inc.) · SBRA (Sabra Health Care REIT, Inc.) · DOC (Healthpeak Properties, Inc.) · XRN (Chiron Real Estate Inc.)
Home Stocks NHI

Latest news

Latest News

MarketBeat40d ago
MSN138d agoLeadership Change
MarketBeat139d ago
Markets Mojo139d ago
MSN139d agoEarnings
Nashville Post132d ago
Yahoo Finance38d agoEarnings
Yahoo Finance141d ago
MarketBeat36d ago
Insider Monkey133d ago
Simplywall.st43d ago
Dars.gov.et43d ago
Quiver Quantitative36d agoEarnings
MarketBeat140d agoEarnings
MarketBeat34d agoEarnings
Kalkine Media35d ago
Simplywall.st35d ago
Kalkine Media35d ago
MarketBeat35d ago
Yahoo Finance132d ago
Loading more...